Literature DB >> 11803457

Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice.

K Yamada1, Y Santo-Yamada, E Wada, K Wada.   

Abstract

Bombesin (BN)-like peptides are involved in the regulation of a wide variety of behaviors, such as spontaneous activity and feeding. We assessed the role of BN-like peptides/receptors in emotional and/or anxiety-related behavior using three strains of knockout mice, each deficient in a single BN-like peptide receptor (gastrin-releasing peptide receptor, bombesin receptor subtype-3, or neuromedin B receptor). Two representative behavioral paradigms, the light-dark (L-D) box test and the elevated plus maze test, were chosen for this purpose. In these two tests, the level of anxiety can be measured as the preference for exploring the light box, or the length of time spent in the open arms, respectively. By conventional parameters, the only significant finding was that BRS-3-deficient mice exhibited a longer duration of remaining in the open arms compared to the wild-type cohort (P < 0.01). However, analyses of risk assessment behavior revealed that BRS-3-deficient mice exhibited increased 'stretched attend posture' behavior (P < 0.01, compared to wild-type mice in both the L-D box and elevated plus maze tests) while NMB-R-deficient mice exhibited decreased behavior (P < 0.05, compared to wild-type mice in both tests). These results suggest that BN-like peptides/receptors may play a role in modulating emotion including some forms of anxiety (e.g., risk assessment behavior). Further, we found that the type of emotional behavior to which each of the peptide/receptor pathways contributes can be clearly specified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803457     DOI: 10.1038/sj.mp.4000974

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  15 in total

1.  Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients.

Authors:  Marc L Reitman; Victor Dishy; Allison Moreau; William S Denney; Chengcheng Liu; Walter K Kraft; Alex V Mejia; Mark A Matson; S Aubrey Stoch; John A Wagner; Eseng Lai
Journal:  J Clin Pharmacol       Date:  2011-12-12       Impact factor: 3.126

2.  Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.

Authors:  Veronica Sancho; Terry W Moody; Samuel A Mantey; Alessia Di Florio; Hirotsugu Uehara; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2010-05-12       Impact factor: 3.750

3.  Receptor-specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3.

Authors:  Yan Zhang; Yanfang Liu; Lehao Wu; Chao Fan; Zhiwei Wang; Xiuli Zhang; Amal Alachkar; Xinmiao Liang; Olivier Civelli
Journal:  FASEB J       Date:  2018-01-22       Impact factor: 5.191

Review 4.  Bombesin-Like Receptor 3: Physiology of a Functional Orphan.

Authors:  Cuiying Xiao; Marc L Reitman
Journal:  Trends Endocrinol Metab       Date:  2016-04-04       Impact factor: 12.015

Review 5.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

Review 6.  Bombesin receptor subtype 3 as a potential target for obesity and diabetes.

Authors:  Nieves González; Paola Moreno; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2015-06-12       Impact factor: 6.902

7.  Female mice target deleted for the neuromedin B receptor have partial resistance to diet-induced obesity.

Authors:  Gabriela Silva Monteiro Paula; Luana Lopes Souza; Adriana Cabanelas; Flavia Fonseca Bloise; Valéria Mello-Coelho; Etsuko Wada; Tania Maria Ortiga-Carvalho; Karen Jesus Oliveira; Carmen Cabanelas Pazos-Moura
Journal:  J Physiol       Date:  2010-03-08       Impact factor: 5.182

8.  Effects of N-acetylcysteine/deferoxamine, taurine and RC-3095 on respiratory chain complexes and creatine kinase activities in rat brain after sepsis.

Authors:  Omar J Cassol; Gislaine T Rezin; Fabrícia C Petronilho; Giselli Scaini; Cinara L Gonçalves; Gabriela K Ferreira; Rafael Roesler; Gilberto Schwartsmann; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

9.  Facilitation of the inhibitory transmission by gastrin-releasing peptide in the anterior cingulate cortex.

Authors:  XiaoYan Cao; Valentina Mercaldo; Pingyang Li; Long-Jun Wu; Min Zhuo
Journal:  Mol Pain       Date:  2010-09-13       Impact factor: 3.395

10.  Factors contributing to obesity in bombesin receptor subtype-3-deficient mice.

Authors:  Ellen E Ladenheim; Nahketah L Hamilton; Robert R Behles; Sheng Bi; Lori L Hampton; James F Battey; Timothy H Moran
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.